Lonnie D Shea Selected Research

Polyglactin 910

10/2020	Modulating lung immune cells by pulmonary delivery of antigen-specific nanoparticles to treat autoimmune disease.
1/2020	Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease.
1/2018	Feasibility study on mouse live imaging after spinal cord injury and poly(lactide-co-glycolide) bridge implantation.
1/2017	Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance.
1/2017	An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
8/2015	Poly(lactide-co-glycolide) microspheres for MRI-monitored delivery of sorafenib in a rabbit VX2 model.
6/2014	Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors.
11/2013	Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia.
4/2009	Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lonnie D Shea Research Topics

Disease

32	Neoplasms (Cancer) 01/2021 - 06/2009
17	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 06/2005
16	Inflammation (Inflammations) 12/2020 - 09/2004
13	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021 - 07/2011
12	Breast Neoplasms (Breast Cancer) 10/2021 - 10/2007
11	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2008
10	Autoimmune Diseases (Autoimmune Disease) 11/2020 - 03/2014
6	Multiple Sclerosis 10/2020 - 03/2014
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2020 - 12/2012
5	Infertility (Sterility) 11/2014 - 04/2006
4	Hypersensitivity (Allergy) 01/2020 - 05/2016
4	Carcinoma (Carcinomatosis) 05/2010 - 04/2008
3	Wounds and Injuries (Trauma) 12/2022 - 06/2008
3	Disease Progression 01/2020 - 01/2019
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 05/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2021
2	Triple Negative Breast Neoplasms 01/2021 - 10/2017
2	Hypertrophy 12/2020 - 05/2017
2	Diabetes Mellitus 11/2020 - 05/2018
2	Prostatic Neoplasms (Prostate Cancer) 07/2020 - 01/2018
2	Primary Ovarian Insufficiency 11/2015 - 12/2011
2	Hepatocellular Carcinoma (Hepatoma) 08/2015 - 06/2014
2	Ovarian Epithelial Carcinoma 01/2013 - 05/2010
2	Ovarian Neoplasms (Ovarian Cancer) 06/2008 - 04/2008
2	Weight Gain 05/2008 - 08/2006
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2008 - 09/2005
1	Peanut Hypersensitivity (Peanut Allergy) 01/2022
1	Food Hypersensitivity (Food Allergy) 01/2022
1	Paralysis (Palsy) 01/2021
1	Carcinogenesis 01/2021
1	Metabolic Diseases (Metabolic Disease) 12/2020
1	Obesity 12/2020
1	Meningomyelocele (Myelomeningocele) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Celiac Disease (Celiac Sprue) 01/2020
1	Neural Tube Defects (Exencephaly) 01/2020
1	Spinal Dysraphism (Spina Bifida) 01/2020

Drug/Important Bio-Agent (IBA)

14	Biocompatible Materials (Biomaterials)IBA 01/2021 - 08/2011
10	Proteins (Proteins, Gene)FDA Link 11/2020 - 04/2008
10	AntigensIBA 10/2020 - 12/2012
9	Polyglactin 910IBA 10/2020 - 04/2009
7	HydrogelsIBA 01/2021 - 04/2011
6	Interleukin-10 (Interleukin 10)IBA 01/2021 - 02/2014
6	CytokinesIBA 12/2020 - 02/2014
5	Transcription Factors (Transcription Factor)IBA 07/2020 - 01/2013
5	CollagenIBA 03/2016 - 04/2008
4	Insulin (Novolin)FDA Link 10/2021 - 05/2017
4	Peptides (Polypeptides)IBA 01/2017 - 05/2012
3	PolymersIBA 12/2020 - 06/2005
3	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 08/2006
3	Conditioned Culture MediaIBA 01/2020 - 12/2015
2	Transforming Growth Factor beta (TGF-beta)IBA 12/2022 - 02/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2008
2	Trastuzumab (Herceptin)FDA Link 11/2020 - 10/2018
2	FibrinIBA 01/2020 - 11/2014
2	Biological ProductsIBA 10/2019 - 04/2006
2	Methylprednisolone FDA LinkGeneric 01/2019 - 01/2016
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2019 - 01/2008
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2013
2	AutoantigensIBA 01/2018 - 03/2014
2	Sorafenib (BAY 43-9006)FDA Link 08/2015 - 06/2014
2	GelsIBA 01/2013 - 04/2008
2	Complementary DNA (cDNA)IBA 08/2009 - 06/2008
2	GoldIBA 01/2008 - 09/2005
1	AllergensIBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2021
1	CyclinsIBA 10/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 12/2020
1	Blood Glucose (Blood Sugar)IBA 12/2020
1	Biopolymers (Biopolymer)IBA 12/2020
1	Cyclin EIBA 11/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 07/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Glutens (Glutelin)IBA 01/2020
1	HLA-DQ8 antigenIBA 01/2020
1	GliadinIBA 01/2020
1	polycaprolactoneIBA 01/2020
1	EnzymesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	poly(lactide) (polylactic acid)IBA 11/2019
1	Tumor Biomarkers (Tumor Markers)IBA 11/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2019

Therapy/Procedure

27	Therapeutics 10/2021 - 06/2008
12	Transplantation 10/2020 - 08/2006
7	Islets of Langerhans Transplantation 01/2019 - 01/2013
5	Immunotherapy 01/2022 - 05/2016
5	Drug Therapy (Chemotherapy) 10/2018 - 08/2009
3	Immunomodulation 01/2021 - 01/2018
3	Microspheres (Microsphere) 08/2015 - 05/2006
2	Autologous Transplantation 01/2017 - 12/2011
2	Cell Transplantation 11/2016 - 09/2011
2	Radiotherapy 07/2014 - 10/2009
1	Intravenous Administration 01/2021
1	Denervation 01/2021
1	Glycemic Control 11/2020
1	Aftercare (After-Treatment) 11/2020
1	Intravenous Injections 01/2020
1	Precision Medicine 01/2020